Log In
BCIQ
Print this Print this
 

RG6125 (formerly SDP051)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionHumanized mAb against cadherin 11 (Cad-11; CDH11)
Molecular Target Cadherin 11 (Cad-11) (CDH11)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$580.0M

$105.0M

$475.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/09/2015

$580.0M

$105.0M

$475.0M

Get a free BioCentury trial today